Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Challenges and Considerations of Preclinical Development for iPSC-Based Myogenic Cell Therapy

29 Mar 2024

Abstract excerpt

Cell therapies derived from induced pluripotent stem cells (iPSCs) offer a promising avenue in the field of regenerative medicine due to iPSCs' expandability, immune compatibility, and pluripotent potential. An increasing number of preclinical and clinical trials have been carried out, exploring the application of iPSC-based therapies for challenging diseases, such as muscular dystrophies. The unique syncytial...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Pluripotent Stem Cells Research
Share to Tissue Engineering and Regenerative Medicine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38607035
DOI: 10.3390/cells13070596

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Challenges and Considerations of Preclinical Development for iPSC-Based Myogenic Cell TherapyPMID 38607035Read ↗

Myogenic Precursors from iPS Cells for Skeletal Muscle Cell Replacement TherapySemantic proximity Read ↗

Current Progress and Challenges for Skeletal Muscle Differentiation from Human Pluripotent Stem Cells Using Transgene-Free ApproachesSemantic proximity Read ↗

Simple and efficient differentiation of human iPSCs into contractible skeletal muscles for muscular disease modelingSemantic proximity Read ↗

Myogenic Differentiation of Muscular Dystrophy-Specific Induced Pluripotent Stem Cells for Use in Drug DiscoverySemantic proximity Read ↗

Skeletal Muscle Cell Induction from Pluripotent Stem CellsSemantic proximity Read ↗

Human induced pluripotent stem cell models for the study and treatment of Duchenne and Becker muscular dystrophiesSemantic proximity Read ↗

Multilineage Differentiation for Formation of Innervated Skeletal Muscle Fibers from Healthy and Diseased Human Pluripotent Stem CellsSemantic proximity Read ↗

Pluripotent Stem Cells in Disease Modeling and Drug Discovery for Myotonic Dystrophy Type 1Semantic proximity Read ↗

Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an <i>in vitro</i> model and for therapy of muscular dystrophiesSemantic proximity Read ↗

Versatility of Induced Pluripotent Stem Cells (iPSCs) for Improving the Knowledge on Musculoskeletal DiseasesSemantic proximity Read ↗

Induction of Skeletal Muscle Progenitors and Stem Cells from human induced Pluripotent Stem CellsSemantic proximity Read ↗

Simple and efficient differentiation of human iPSCs into contractible skeletal muscles for muscular disease modelingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.